en-USen-GB
  • Tokyo 5-6 November 2018
    Tokyo 5-6 November 2018
  • Princeton 1-3 May 2018
    Princeton 1-3 May 2018
  • Darmstadt, 15-17 May 2018
    Darmstadt, 15-17 May 2018
  • Tokyo 4-5 December 2017
    Tokyo 4-5 December 2017
  • Wellesely, MA 16-18 October 2017
    Wellesely, MA 16-18 October 2017
  • BERLIN 26-28 SEP 2017
    BERLIN 26-28 SEP 2017
  • REYKJAVIK 8-10 MAY 2017
    REYKJAVIK 8-10 MAY 2017
  • BLUE BELL, PA 24-26 OCT 2016
    BLUE BELL, PA 24-26 OCT 2016
  • BASEL 10-12 OCT 2016
    BASEL 10-12 OCT 2016
  • SINGAPORE 1-3 JUNE 2016
    SINGAPORE 1-3 JUNE 2016
  • UPPSALA 17-19 MAY 2016
    UPPSALA 17-19 MAY 2016
  • INDIANAPOLIS 25-27 APR 2016
    INDIANAPOLIS 25-27 APR 2016
  • NEW YORK 19-21 OCT 2015
    NEW YORK 19-21 OCT 2015
  • HORSHAM 5-7 OCT 2015
    HORSHAM 5-7 OCT 2015
  • SINGAPORE 3-4 SEP 2015
    SINGAPORE 3-4 SEP 2015
  • NORTH WALES, PA 18-20 MAY 2015
    NORTH WALES, PA 18-20 MAY 2015
  • SIENA 28-30 APR 2015
    SIENA 28-30 APR 2015
  • BANGALORE 5-6 FEB 2015
    BANGALORE 5-6 FEB 2015
  • CAMBRIDGE, MA 22-24 OCT 2014
    CAMBRIDGE, MA 22-24 OCT 2014
  • COPENHAGEN 16-18 SEP 2014
    COPENHAGEN 16-18 SEP 2014
  • SINGAPORE 20-21 MAY 2014
    SINGAPORE 20-21 MAY 2014
  • AMSTERDAM 14-16 MAY 2014
    AMSTERDAM 14-16 MAY 2014
  • BOULDER 30 APR - 2 MAY 2014
    BOULDER 30 APR - 2 MAY 2014
  • RESTON, VA 28-30 OCT 2013
    RESTON, VA 28-30 OCT 2013
  • DUBLIN 18-20 SEP 2013
    DUBLIN 18-20 SEP 2013
  • KASNSAS CITY 7-9 MAY 2013
    KASNSAS CITY 7-9 MAY 2013
  • EDINBURGH 22-24 APR 2013
    EDINBURGH 22-24 APR 2013
  • MONTVILLE, NJ 14-16 NOV 2012
    MONTVILLE, NJ 14-16 NOV 2012
  • MADRID 1-3 OCT 2012
    MADRID 1-3 OCT 2012
  • PARIS 21-23 MAY 2012
    PARIS 21-23 MAY 2012
  • EAST HANOVER, NJ 7-8 MAY 2012
    EAST HANOVER, NJ 7-8 MAY 2012
  • STRASBOURG 28-30 NOV 2011
    STRASBOURG 28-30 NOV 2011
  • NEWPORT BEACH 2-3 NOV 2011
    NEWPORT BEACH 2-3 NOV 2011
  • BANBURY 4-6 MAY 2011
    BANBURY 4-6 MAY 2011
  • CAMBRIDGE, MA 12-13 APRIL 2011
    CAMBRIDGE, MA 12-13 APRIL 2011
  • FORT LAUDERDALE 3-5 NOV 2010
    FORT LAUDERDALE 3-5 NOV 2010
  • BRUSSELS 6-8 OCT 2010
    BRUSSELS 6-8 OCT 2010
  • PARIS 5-7 MAY 2010
    PARIS 5-7 MAY 2010

WHO WE ARE

The eClinical Forum is a global network of peers. It provides a non‐competitive environment for innovation, learning and collaboration in clinical research.


News from the eCF

Login to also view news for Members.

Netherlands initiative to assess electronic health record systems using eCF eSRA tool

Partnering for Success

  • 17 February 2016
  • Author: Webmaster
  • Number of views: 7533
  • 0 Comments
Netherlands initiative to assess electronic health record systems using eCF eSRA tool

NL initiative to assess electronic health record systems using eCF eSRA tool

The Dutch Clinical Trial Foundation (DCTF) has endorsed an EHR working group committed to the implementation of one uniform tool for the validation of electronic health record (EHR) systems used at clinical research sites within the Netherlands. The group consists of representatives from several pharmaceutical companies, CROs and hospitals, and is chaired by Martijn Griep, Johnson & Johnson Regional QC Manager, coordinated by Dana De Beuckelaer-Dournez from the University of Antwerp.

After considerable research and discussion with national stakeholders, the working group has chosen to use the eSRA (eSource-Readiness Assessment) program to harmonize the review of the EHR systems and to prove compliance against appropriate clinical research regulations and guidances. eSRA is provided for free by the eClinical Forum (a non-profit, non-commercial discussion/action group comprised of members of the Pharmaceutical and Clinical Research Services industry).This tool is intended to make the clinical research process more efficient, while furthering the use of EHR records for clinical research. Clinical research sites are often asked by their clinical trial sponsors to complete questionnaires regarding their EHR system. With each sponsor having its own questionnaire, completing a different form for each sponsor can be very time consuming. By using the eSRA system to complete a standard form, they can do it once and provide it to all their sponsors. And, since eSRA is based on the EMA and FDA regulations, the resulting report is appropriate to share with regulators.

The EHR working group started a pilot in three big hospitals to assess their systems using eSRA. Ellen Rusch, scientific member Scientific Institution, Martini Hospital Groningen and one of the members of the working group, was the first to complete the process.. She reported that the website that hosts the eSRA system was easy to use without any training.  She worked with her IT support staff, and together they were able to complete the assessment in only 30 minutes! “We do about 50-80 trials each year and we are receiving a new sponsor questionnaire to complete about every 2 weeks. Each sponsor has their own form with questions worded differently, so it is very time consuming to work through each questionnaire. Each sponsor form takes an hour or more to read the new form, determine the answers and file the form. Then we must wait for the sponsor to review the form and sometimes re-work if there are any errors, etc. Some pharma-provided forms can be rather long, even though they all seem to ask the same questions, just in a different format each time. By doing the eSRA assessment once, knowing that it has been completed correctly, and providing the resulting report to the sponsors, we will save a lot of time. In addition, by registering for notifications, the eSRA system will notify us if any clinical research regulations have changed that we should be aware of.”

Martijn Griep, J&J, says “The completion of an eSRA assessment by the Martini Hospital is an important first step towards the registration of more sites and towards gaining the interest of large EHR system vendors to cooperate. By having the EHR vendors complete a pre-assessment of their systems, eSRA can be even more efficient, as these vendor assessments will be used as a resource for our clinical research sites when they complete their site assessments, so that all sites in the NL can use eSRA to assess their systems. Our vision is that all clinical research sites in the Netherlands will be assessed using eSRA and to facilitate eSRA recognition by all sponsors and regulators. We are very grateful to the eClinical Forum for providing this free tool.”

The EHR working group is planning further roll out to more clinical research sites in the NL and mutual acceptance by pharmaceutical companies such that eSRA can replace their own questionnaires. They believe this will avoid duplication of efforts by the completion of various forms and it will contribute to more efficient and reliable data collection in clinical trials.

 

Print
Tags:
Rate this article:
No rating

x

Not a member?
Visit the Membership page to learn 
How To Become a Member
(Join the eClinical Forum and learn how to leverage existing and emerging technologies for electronic clinical trials. Access an eClinical community, member-only knowledge, events and forums)

«July 2018»
MonTueWedThuFriSatSun
2526272829301
2345678
9101112131415
16171819202122
232425
7/25/2018 UTC
62

Birds-of-a-Feather Discussion:  Principal Investigator signature / approval on eCOA Data

Facilitator: Shelby Abel, Bioverativ a Sanofi Company

For This Topic:   “Experience with exceptions of PI signature/Approval on eCOA Data. Please bring your experience and thoughts.”  This is a facilitated discussion with the content coming from the sharing of participants experiences, comments, and questions on this topic.

Read more
26272829
303112345

Upcoming events Events RSSiCalendar export